Response to SDGs

The United Nations’ 2030 Agenda for Sustainable Development outlines 17 Sustainable Development Goals (SDGs), which address urgent global issues such as poverty eradication, ending hunger, employment and economic growth, and climate action. These goals aim to guide the actions of governments, businesses, and civil society organizations toward building a sustainable future together.

While the SDGs highlight pressing challenges that require immediate solutions, they also represent opportunities for corporate growth. By aligning product strategies with specific SDG themes, companies can expand their market presence and enhance their reputation.

As a new drug development company, Medigen is closely aligned with SDG 3: “Good Health and Well-being.” Through the development of innovative pharmaceuticals, we contribute to combating infectious diseases, improving access to vaccines and medicines, and strengthening global health systems. Furthermore, Medigen incorporates SDG considerations into the formulation of internal policies and operational strategies to ensure that the company’s development direction remains consistent with the priorities of our stakeholders.